C WorldWide Group Holding A S Sells 1,770 Shares of Chemed Corporation $CHE

C WorldWide Group Holding A S lowered its stake in shares of Chemed Corporation (NYSE:CHE) by 34.6% during the second quarter, Holdings Channel.com reports. The firm owned 3,347 shares of the company’s stock after selling 1,770 shares during the quarter. C WorldWide Group Holding A S’s holdings in Chemed were worth $1,559,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Geneos Wealth Management Inc. boosted its holdings in shares of Chemed by 330.4% in the 1st quarter. Geneos Wealth Management Inc. now owns 99 shares of the company’s stock valued at $61,000 after buying an additional 76 shares in the last quarter. Arrowstreet Capital Limited Partnership boosted its position in shares of Chemed by 67.0% in the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 11,365 shares of the company’s stock worth $5,534,000 after purchasing an additional 4,560 shares in the last quarter. Marshall Wace LLP purchased a new position in Chemed during the 2nd quarter worth $579,000. Brown Advisory Inc. increased its position in Chemed by 36.9% during the 2nd quarter. Brown Advisory Inc. now owns 549 shares of the company’s stock valued at $267,000 after buying an additional 148 shares in the last quarter. Finally, Cerity Partners LLC raised its stake in Chemed by 237.7% in the second quarter. Cerity Partners LLC now owns 4,451 shares of the company’s stock valued at $2,165,000 after buying an additional 3,133 shares during the last quarter. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Chemed Stock Performance

CHE opened at $519.96 on Wednesday. The company has a current ratio of 0.91, a quick ratio of 0.89 and a debt-to-equity ratio of 0.17. Chemed Corporation has a 12-month low of $365.20 and a 12-month high of $557.00. The firm has a 50 day moving average of $519.00 and a two-hundred day moving average of $452.37. The firm has a market capitalization of $6.80 billion, a PE ratio of 26.12, a P/E/G ratio of 1.97 and a beta of 0.51.

Chemed (NYSE:CHE) last released its quarterly earnings data on Tuesday, July 28th. The company reported $6.06 EPS for the quarter, beating the consensus estimate of $5.60 by $0.46. Chemed had a net margin of 10.60% and a return on equity of 31.77%. The business had revenue of $673.25 million for the quarter, compared to the consensus estimate of $665.04 million. During the same period in the prior year, the firm earned $4.27 EPS. The business’s revenue for the quarter was up 8.8% on a year-over-year basis. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. On average, analysts anticipate that Chemed Corporation will post 23.18 EPS for the current year.

Chemed Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, September 3rd. Investors of record on Monday, August 17th were given a dividend of $0.70 per share. This is an increase from Chemed’s previous quarterly dividend of $0.60. This represents a $2.80 annualized dividend and a yield of 0.5%. The ex-dividend date was Monday, August 17th. Chemed’s dividend payout ratio (DPR) is 14.06%.

Insider Buying and Selling at Chemed

In other news, Director Patrick P. Grace sold 190 shares of Chemed stock in a transaction that occurred on Friday, July 31st. The shares were sold at an average price of $532.00, for a total transaction of $101,080.00. Following the completion of the transaction, the director directly owned 3,533 shares of the company’s stock, valued at $1,879,556. The trade was a 5.10% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the business’s stock in a transaction on Monday, August 3rd. The shares were sold at an average price of $539.51, for a total transaction of $1,079,020.00. Following the completion of the transaction, the chief executive officer owned 70,418 shares of the company’s stock, valued at approximately $37,991,215.18. This represents a 2.76% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last ninety days, insiders sold 5,190 shares of company stock valued at $2,803,460. 3.33% of the stock is owned by company insiders.

Analyst Ratings Changes

CHE has been the topic of a number of research analyst reports. Oppenheimer boosted their price target on Chemed from $500.00 to $590.00 and gave the stock an “outperform” rating in a research note on Friday, July 31st. Royal Bank Of Canada boosted their target price on shares of Chemed from $436.00 to $548.00 and gave the stock a “sector perform” rating in a research report on Thursday, July 30th. Weiss Ratings raised shares of Chemed from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, July 17th. Wall Street Zen upgraded shares of Chemed from a “hold” rating to a “strong-buy” rating in a research note on Saturday, August 1st. Finally, Bank of America reissued a “neutral” rating on shares of Chemed in a research report on Wednesday, July 29th. One research analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $530.75.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.